Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of once-daily Kaletra and methadone in HIV-positive drug users
2009-015647-16Phase 4Terminated
- Sponsor
- GUIDE Clinic
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV) and opioid use disorder (OUD), sponsored by GUIDE Clinic. Primary endpoint: Pharmacokinetics of once-daily Kaletra and methadone. Started Sep 2009; status: terminated.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)opioid use disorder (OUD)
Beyond the preview
Go deeper on 2009-015647-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015647-16.